• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早年家族性肺毛细血管血管瘤病

Familial pulmonary capillary hemangiomatosis early in life.

作者信息

Wirbelauer Johannes, Hebestreit Helge, Marx Alexander, Mark Eugene J, Speer Christian P

机构信息

University Children's Hospital, University of Wuerzburg, Josef-Schneider-Straße 2, 97080 Wuerzburg, Germany.

出版信息

Case Rep Pulmonol. 2011;2011:827591. doi: 10.1155/2011/827591. Epub 2011 Dec 19.

DOI:10.1155/2011/827591
PMID:22937432
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3420428/
Abstract

Background. Pulmonary capillary hemangiomatosis (PCH) is a rare disease, especially in infancy. Four infants have been reported up to the age of 12 months. So far, no familial patients are observed at this age. Patients. We report three siblings, two female newborns and a foetus of 15-week gestation of unrelated, healthy parents suffering from histologically proven PCH. The first girl presented with increased O(2) requirements shortly after birth and patent ductus arteriosus (PDA). She subsequently developed progressive respiratory failure and pulmonary hypertension and died at the age of five months. The second girl presented with clinical signs of bronchial obstruction at the age of three months. The work-up showed a PDA-which was surgically closed-pulmonary hypertension, and bronchial wall instability with stenosis of the left main bronchus. Transient oxygen therapy was required with viral infections. The girl is now six years old and clinically stable without additional O(2) requirements. Failure to thrive during infancy and a somewhat delayed development may be the consequence of the disease itself but also could be attributed to repeated episodes of respiratory failure and a long-term systemic steroid therapy. The third pregnancy ended as spontaneous abortion. The foetus showed histological signs of PCH. Conclusion. Despite the differences in clinical course, the trias of PCH, PDA, and pulmonary hypertension in the two life born girls suggests a genetic background.

摘要

背景。肺毛细血管瘤病(PCH)是一种罕见疾病,在婴儿期尤为罕见。据报道,12个月龄以下的患儿有4例。迄今为止,该年龄段未观察到家族性患者。患者。我们报告了3例患PCH的同胞患儿,父母为健康非近亲,其中2例为女新生儿,1例为妊娠15周的胎儿,均经组织学确诊。第一个女孩出生后不久即出现氧需求增加及动脉导管未闭(PDA)。随后她逐渐发展为进行性呼吸衰竭和肺动脉高压,并于5个月龄时死亡。第二个女孩3个月龄时出现支气管阻塞的临床症状。检查发现PDA(已手术闭合)、肺动脉高压以及左主支气管狭窄导致的支气管壁不稳定。病毒感染时需要短暂吸氧治疗。该女孩现6岁,临床稳定,无需额外吸氧。婴儿期生长发育不良和发育稍延迟可能是疾病本身所致,也可能归因于反复的呼吸衰竭发作和长期全身使用类固醇治疗。第三次妊娠以自然流产告终。胎儿显示有PCH的组织学特征。结论。尽管临床病程存在差异,但两名存活女婴均出现PCH、PDA和肺动脉高压三联征,提示存在遗传背景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d726/3420428/54d6975c6e73/CRIM.PULMONOLOGY2011-827591.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d726/3420428/d7d02711cc13/CRIM.PULMONOLOGY2011-827591.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d726/3420428/32d8aa5ff4a1/CRIM.PULMONOLOGY2011-827591.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d726/3420428/54d6975c6e73/CRIM.PULMONOLOGY2011-827591.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d726/3420428/d7d02711cc13/CRIM.PULMONOLOGY2011-827591.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d726/3420428/32d8aa5ff4a1/CRIM.PULMONOLOGY2011-827591.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d726/3420428/54d6975c6e73/CRIM.PULMONOLOGY2011-827591.003.jpg

相似文献

1
Familial pulmonary capillary hemangiomatosis early in life.早年家族性肺毛细血管血管瘤病
Case Rep Pulmonol. 2011;2011:827591. doi: 10.1155/2011/827591. Epub 2011 Dec 19.
2
Pulmonary capillary hemangiomatosis: a case series and review of literature.肺毛细血管血管瘤病:病例系列及文献综述
Am J Cardiovasc Dis. 2021 Apr 15;11(2):239-245. eCollection 2021.
3
Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.布洛芬用于治疗早产和/或低出生体重婴儿的动脉导管未闭。
Cochrane Database Syst Rev. 2008 Jan 23(1):CD003481. doi: 10.1002/14651858.CD003481.pub3.
4
Pulmonary capillary hemangiomatosis associated with primary pulmonary hypertension: report of 2 new cases and review of 35 cases from the literature.与原发性肺动脉高压相关的肺毛细血管瘤病:2例新病例报告及文献中35例病例回顾
Medicine (Baltimore). 2002 Nov;81(6):417-24. doi: 10.1097/00005792-200211000-00002.
5
Different sizes of centrilobular ground-glass opacities in chest high-resolution computed tomography of patients with pulmonary veno-occlusive disease and patients with pulmonary capillary hemangiomatosis.肺静脉闭塞病和肺毛细血管血管瘤病患者胸部高分辨率 CT 的不同大小的中央性磨玻璃密度影。
Cardiovasc Pathol. 2013 Jul-Aug;22(4):287-93. doi: 10.1016/j.carpath.2012.12.002. Epub 2013 Jan 10.
6
Pulmonary capillary hemangiomatosis-predominant vasculopathy in a patient with rheumatoid arthritis-associated interstitial lung disease: An autopsy report.类风湿关节炎相关间质性肺疾病患者以肺毛细血管血管瘤病为主的血管病变:一份尸检报告
Respir Med Case Rep. 2020 Sep 8;31:101215. doi: 10.1016/j.rmcr.2020.101215. eCollection 2020.
7
The effect of hemodynamically significant patent ductus arteriosus on acute kidney injury and systemic hypertension in extremely low gestational age newborns.血流动力学显著的动脉导管未闭对极早早产儿急性肾损伤和系统性高血压的影响。
J Matern Fetal Neonatal Med. 2019 Oct;32(19):3209-3214. doi: 10.1080/14767058.2018.1460349. Epub 2018 Apr 12.
8
Indomethacin tocolysis increases postnatal patent ductus arteriosus severity.吲哚美辛抑制宫缩会增加出生后动脉导管未闭的严重程度。
Pediatrics. 1998 Nov;102(5):E56. doi: 10.1542/peds.102.5.e56.
9
Clinical prediction score for identifying patients with pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis.用于识别肺静脉闭塞病/肺毛细血管血管瘤病患者的临床预测评分。
J Cardiol. 2018 Sep;72(3):255-260. doi: 10.1016/j.jjcc.2018.02.009. Epub 2018 Mar 13.
10
[Pulmonary capillary hemangiomatosis: a case report and literature review].[肺毛细血管瘤病:一例报告及文献复习]
Beijing Da Xue Xue Bao Yi Xue Ban. 2015 Oct 18;47(5):865-9.

引用本文的文献

1
Pulmonary capillary hemangiomatosis: a case series and review of literature.肺毛细血管血管瘤病:病例系列及文献综述
Am J Cardiovasc Dis. 2021 Apr 15;11(2):239-245. eCollection 2021.
2
Pulmonary capillary haemangiomatosis: a distinct entity?肺毛细血管血管瘤病:一种独特的实体?
Eur Respir Rev. 2020 May 27;29(156). doi: 10.1183/16000617.0168-2019. Print 2020 Jun 30.
3
Pulmonary Capillary Hemangiomatosis without Pulmonary Hypertension: An Early Stage of Disease?无肺动脉高压的肺毛细血管血管瘤病:疾病的早期阶段?

本文引用的文献

1
[Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis].[肺静脉闭塞病和肺毛细血管瘤病]
Presse Med. 2010 Jan;39(1):134-43. doi: 10.1016/j.lpm.2009.09.013. Epub 2009 Nov 13.
2
[Hematologic or immunologic disease as cause of cardiopulmonary distress].
Klin Padiatr. 2009 Sep;221(5):273-4. doi: 10.1055/s-0029-1237370. Epub 2009 Aug 25.
3
Updated clinical classification of pulmonary hypertension.肺动脉高压的更新临床分类。
J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S43-S54. doi: 10.1016/j.jacc.2009.04.012.
Chin Med J (Engl). 2018 Jan 20;131(2):245-246. doi: 10.4103/0366-6999.222326.
4
A 16q deletion involving FOXF1 enhancer is associated to pulmonary capillary hemangiomatosis.一段涉及 FOXF1 增强子的 16q 缺失与肺毛细血管血管瘤病相关。
BMC Med Genet. 2015 Oct 13;16:94. doi: 10.1186/s12881-015-0241-7.
5
Pulmonary capillary hemangiomatosis: a focus on the EIF2AK4 mutation in onset and pathogenesis.肺毛细血管血管瘤病:聚焦于EIF2AK4突变在发病及发病机制中的作用
Appl Clin Genet. 2015 Aug 7;8:181-8. doi: 10.2147/TACG.S68635. eCollection 2015.
6
EIF2AK4 mutations in pulmonary capillary hemangiomatosis.EIF2AK4 突变与肺毛细血管血管瘤病。
Chest. 2014 Feb;145(2):231-236. doi: 10.1378/chest.13-2366.
4
Genomic and genic deletions of the FOX gene cluster on 16q24.1 and inactivating mutations of FOXF1 cause alveolar capillary dysplasia and other malformations.16号染色体长臂24.1区域FOX基因簇的基因组和基因缺失以及FOXF1的失活突变会导致肺泡毛细血管发育异常和其他畸形。
Am J Hum Genet. 2009 Jun;84(6):780-91. doi: 10.1016/j.ajhg.2009.05.005. Epub 2009 Jun 4.
5
Lymph node pathology in pulmonary veno-occlusive disease and pulmonary capillary heamangiomatosis.
Virchows Arch. 2008 Aug;453(2):171-6. doi: 10.1007/s00428-008-0636-3. Epub 2008 Jun 13.
6
Pulmonary capillary hemangiomatosis imaging findings and literature update.肺毛细血管血管瘤病的影像学表现及文献综述
J Comput Assist Tomogr. 2007 Jul-Aug;31(4):608-10. doi: 10.1097/01.rct.0000284393.76073.87.
7
From the Archives of the AFIP: pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.源自武装部队病理研究所档案:肺静脉闭塞性疾病与肺毛细血管瘤病
Radiographics. 2007 May-Jun;27(3):867-82. doi: 10.1148/rg.273065194.
8
Molecular mechanisms of pulmonary vascular development.肺血管发育的分子机制
Pediatr Dev Pathol. 2007 Jan-Feb;10(1):1-17. doi: 10.2350/06-06-0122.1.
9
Platelet-derived growth factor is increased in pulmonary capillary hemangiomatosis.血小板衍生生长因子在肺毛细血管瘤病中升高。
Chest. 2007 Mar;131(3):850-855. doi: 10.1378/chest.06-1680.
10
Pulmonary capillary haemangiomatosis in children and adolescents: report of a new case and a review of the literature.儿童和青少年的肺毛细血管血管瘤病:1例新病例报告及文献复习
Eur J Pediatr. 2004 Dec;163(12):731-7. doi: 10.1007/s00431-004-1527-5.